Wyeth 3Q Revenues: $5.1 billion (+9%) 3Q Earnings: $1.2 billion (+33%) YTD Revenues: $15.1 billion (+8%) YTD Earnings: $3.3 billion (+14%) Comments: Enbrel sales, outside of the U.S. and Canada, were $378 million for the quarter and $1.1 billion YTD, increases of 37% and 38%, respectively. Prevnar sales were $510 million for the 2006 third quarter and $1.5 billion for the 2006 first nine months, increases of 30% and 32%, respectively. Effexor sales were $924 million for th...